A study to look at two generations of a medicine (zinpentraxin alfa) – that were manufactured in two different ways – how do they move through the body, from absorption to elimination
A Phase 1 Double-Blind, Randomized, Two-Arm, Two-Way Crossover, Sequential Two-Stage Study to Assess the Pharmacokinetic Comparability of First and Second Generation RO7490677 (Recombinant Human Pentraxin-2; rhPTX-2) Drug Products in Healthy Subjects
Respiratory Disorder Idiopathic Pulmonary Fibrosis (IPF)
For the latest version of this information please go to www.forpatients.roche.com